221 related articles for article (PubMed ID: 21811625)
21. An integrated network of microRNA and gene expression in ovarian cancer.
Quitadamo A; Tian L; Hall B; Shi X
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S5. PubMed ID: 25860109
[TBL] [Abstract][Full Text] [Related]
22. Deregulated microRNA and mRNA expression profiles in the peripheral blood of patients with Marfan syndrome.
Abu-Halima M; Kahraman M; Henn D; Rädle-Hurst T; Keller A; Abdul-Khaliq H; Meese E
J Transl Med; 2018 Mar; 16(1):60. PubMed ID: 29530068
[TBL] [Abstract][Full Text] [Related]
23. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
24. miRNA profiling along tumour progression in ovarian carcinoma.
Vaksman O; Stavnes HT; Kaern J; Trope CG; Davidson B; Reich R
J Cell Mol Med; 2011 Jul; 15(7):1593-602. PubMed ID: 20716115
[TBL] [Abstract][Full Text] [Related]
25. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.
Woo HH; László CF; Greco S; Chambers SK
Mol Cancer; 2012 Aug; 11():58. PubMed ID: 22909061
[TBL] [Abstract][Full Text] [Related]
26. Herpes virus microRNA expression and significance in serous ovarian cancer.
Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
[TBL] [Abstract][Full Text] [Related]
27. Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Laios A; O'Toole S; Flavin R; Martin C; Kelly L; Ring M; Finn SP; Barrett C; Loda M; Gleeson N; D'Arcy T; McGuinness E; Sheils O; Sheppard B; O' Leary J
Mol Cancer; 2008 Apr; 7():35. PubMed ID: 18442408
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression.
Hill CG; Matyunina LV; Walker D; Benigno BB; McDonald JF
BMC Syst Biol; 2014 Mar; 8():36. PubMed ID: 24666724
[TBL] [Abstract][Full Text] [Related]
29. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
[TBL] [Abstract][Full Text] [Related]
31. Differentially expressed microRNAs in pancreatic cancer stem cells.
Jung DE; Wen J; Oh T; Song SY
Pancreas; 2011 Nov; 40(8):1180-7. PubMed ID: 21785383
[TBL] [Abstract][Full Text] [Related]
32. Clinically relevant microRNAs in ovarian cancer.
Zhang S; Lu Z; Unruh AK; Ivan C; Baggerly KA; Calin GA; Li Z; Bast RC; Le XF
Mol Cancer Res; 2015 Mar; 13(3):393-401. PubMed ID: 25304686
[TBL] [Abstract][Full Text] [Related]
33. Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.
Jin D; Lee H
Sci Rep; 2016 Oct; 6():35350. PubMed ID: 27734929
[TBL] [Abstract][Full Text] [Related]
34. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
35. miRNA profile in ovarian cancer.
Ghafouri-Fard S; Shoorei H; Taheri M
Exp Mol Pathol; 2020 Apr; 113():104381. PubMed ID: 31954715
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the importance of post-transcriptional regulatory changes in ovarian cancer progression and the contribution of miRNAs.
Zhang M; Matyunina LV; Walker LD; Chen W; Xiao H; Benigno BB; Wu R; McDonald JF
Sci Rep; 2017 Aug; 7(1):8171. PubMed ID: 28811560
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types.
Bhowmick SS; Bhattacharjee D; Rato L
Comput Biol Chem; 2020 Feb; 84():107152. PubMed ID: 31785969
[TBL] [Abstract][Full Text] [Related]
38. Deep integrative analysis of microRNA-mRNA regulatory networks for biomarker and target discovery in chondrosarcoma.
Sui J; Liu Q; Zhang H; Kong Y
J Cell Biochem; 2019 Jun; 120(6):9631-9638. PubMed ID: 30520120
[TBL] [Abstract][Full Text] [Related]
39. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of directly captured microRNA targets reveals the impact of microRNAs on mammalian transcriptome.
Bjerke GA; Yi R
RNA; 2020 Mar; 26(3):306-323. PubMed ID: 31900330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
